BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8
21 results:

  • 1. Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and Metastases.
    Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
    Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
    Tao X; Xu T; Lin X; Xu S; Fan Y; Guo B; Deng X; Jiao Q; Chen L; Wei Z; Chen C; Yang W; Zhang Z; Yu X; Yue H
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1768-1775. PubMed ID: 36611251
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Fatty acid synthase (Fasn) inhibits the expression levels of immune response genes via alteration of alternative splicing in islet cells.
    Wang K; Li L; Jin J; An Y; Wang Z; Zhou S; Zhang J; Abuduaini B; Cheng C; Li N
    J Diabetes Complications; 2022 Jun; 36(6):108159. PubMed ID: 35210136
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrated Whole-Exome and Transcriptome Sequencing of Sporadic Parathyroid Adenoma.
    Hu Y; Zhang X; Wang O; Cui M; Li X; Wang M; Hua S; Liao Q
    Front Endocrinol (Lausanne); 2021; 12():631680. PubMed ID: 34054720
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transcription factor immunohistochemistry in the diagnosis of pituitary tumours.
    Lenders NF; Wilkinson AC; Wong SJ; Shein TT; Harvey RJ; Inder WJ; Earls PE; McCormack AI
    Eur J Endocrinol; 2021 May; 184(6):891-901. PubMed ID: 33852418
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. circfat1(e2) Promotes Papillary Thyroid cancer Proliferation, Migration, and Invasion via the miRNA-873/ZEB1 Axis.
    Liu J; Li H; Wei C; Ding J; Lu J; Pan G; Mao A
    Comput Math Methods Med; 2020; 2020():1459368. PubMed ID: 33133224
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular profile of Hürthle cell carcinomas: recurrent mutations in the Wnt/β-catenin pathway.
    Santana NO; Lerario AM; Schmerling CK; Marui S; Alves VAF; Hoff AO; Kopp P; Danilovic DLS
    Eur J Endocrinol; 2020 Dec; 183(6):647-656. PubMed ID: 33120354
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genomic and Transcriptomic Characterization of Sporadic Medullary Thyroid Carcinoma.
    Qu N; Shi X; Zhao JJ; Guan H; Zhang TT; Wen SS; Liao T; Hu JQ; Liu WY; Wang YL; Huang S; Shi RL; Wang Y; Ji QH
    Thyroid; 2020 Jul; 30(7):1025-1036. PubMed ID: 32031055
    [No Abstract]    [Full Text] [Related]  

  • 9. Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human cancer Reference panel identifies a malignant signature.
    Mhawech-Fauceglia P; Izevbaye I; Spindler T; Wang G; Hwang H; Samrao D; Elishaev E; Maxwell GL; Lawrenson K; Darcy KM
    Gynecol Oncol; 2020 Jan; 156(1):6-12. PubMed ID: 31711656
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer.
    Harding BN; Delaney JA; Urban RR; Weiss NS
    Gynecol Oncol; 2019 Aug; 154(2):426-431. PubMed ID: 31178150
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Intraoperative MRI in transsphenoidal resection of invasive pituitary macroadenomas.
    Hlaváč M; Knoll A; Etzrodt-Walter G; Sommer F; Scheithauer M; Coburger J; Wirtz CR; Pala A
    Neurosurg Rev; 2019 Sep; 42(3):737-743. PubMed ID: 30949920
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes.
    Hodgson DR; Dougherty BA; Lai Z; Fielding A; Grinsted L; Spencer S; O'Connor MJ; Ho TW; Robertson JD; Lanchbury JS; Timms KM; Gutin A; Orr M; Jones H; Gilks B; Womack C; Gourley C; Ledermann J; Barrett JC
    Br J Cancer; 2018 Nov; 119(11):1401-1409. PubMed ID: 30353044
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Tibolone and risk of gynecological hormone sensitive cancer.
    Løkkegaard ECL; Mørch LS
    Int J Cancer; 2018 Jun; 142(12):2435-2440. PubMed ID: 29349823
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma.
    Miller MB; Bi WL; Ramkissoon LA; Kang YJ; Abedalthagafi M; Knoff DS; Agarwalla PK; Wen PY; Reardon DA; Alexander BM; Laws ER; Dunn IF; Beroukhim R; Ligon KL; Ramkissoon SH
    Oncotarget; 2016 Jun; 7(24):37054-37063. PubMed ID: 27175596
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. n-3 polyunsaturated fatty acids abrogate mTORC1/2 signaling and inhibit adrenocortical carcinoma growth in vitro and in vivo.
    Liu J; Xu M; Zhao Y; Ao C; Wu Y; Chen Z; Wang B; Bai X; Li M; Hu W
    Oncol Rep; 2016 Jun; 35(6):3514-22. PubMed ID: 27035283
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Systemic lupus erythematous and malignancy risk: a meta-analysis.
    Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
    PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas.
    Furukawa T; Sakamoto H; Takeuchi S; Ameri M; Kuboki Y; Yamamoto T; Hatori T; Yamamoto M; Sugiyama M; Ohike N; Yamaguchi H; Shimizu M; Shibata N; Shimizu K; Shiratori K
    Sci Rep; 2015 Mar; 5():8829. PubMed ID: 25743105
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparison of gemcitabine combined with targeted agent therapy versus gemcitabine monotherapy in the management of advanced pancreatic cancer.
    Li Q; Yuan Z; Yan H; Wen Z; Zhang R; Cao B
    Clin Ther; 2014 Jul; 36(7):1054-63. PubMed ID: 24986485
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A soluble form of the giant cadherin fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding.
    Wojtalewicz N; Sadeqzadeh E; Weiß JV; Tehrani MM; Klein-Scory S; Hahn S; Schmiegel W; Warnken U; Schnölzer M; de Bock CE; Thorne RF; Schwarte-Waldhoff I
    PLoS One; 2014; 9(3):e90461. PubMed ID: 24625754
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
    Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
    Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.